Dementia
A virus long thought to be harmless may play a role in Parkinson’s disease, new research suggests. Scientists at Northwestern Medicine detected Human Pegivirus (HPgV) in the brains and spinal fluid of people with Parkinson’s, but not in those without the condition. The virus appeared in half of the Parkinson’s brain samples examined but was [...]
UK-based NRG Therapeutics has raised US$67m (£50m) in series B financing to take its lead drug for Parkinson’s disease and ALS into first-in-human clinical trials. The fundraising round was led by the Dementia Discovery Fund, alongside the venture arms of Novartis and Merck KGaA. The series B funding will support Phase 1 trials of NRG5051, [...]
With high failure rates in neurodegenerative and metabolic disease research, Cantabio Pharmaceuticals is working to close the gap with the development of novel therapeutics and a diagnostic platform for biochemical stress. NR Times speaks to CEO Gergely Toth to find out more. Founded in 2015, Cantabio Pharmaceuticals has been working to develop novel therapies to reduce the [...]
A novel brain scanning technology that has created ‘neural fingerprints’ could enable early diagnosis of neurodegenerative conditions such as dementia. Stephanie Price speaks to Professor Matthew Brooks, chairman of Cerca Magnetics, which has developed the technology, to find out more. A spinout from the University of Nottingham, Cerca Magnetics has developed a lightweight, wearable Cerca [...]
NR Times explores the latest developments in the world of neuro-rehabilitation. Study of killifish reveals how protein dysfunction develops in vertebrate brain cells, shedding light on cognitive decline A new study has shed light on diseases like Alzheimer’s, Parkinson’s, and ALS. Ageing and neurodegeneration are both known to disrupt the production of functional proteins in [...]
People are diagnosed with dementia an average of 3.5 years after symptoms first appear, with early-onset cases facing longer waits of around 4.1 years, new research has foubd. The first global review of dementia diagnosis delays analysed data from 30,257 people in Europe, the US, Australia and China. Delays were longest in younger people and [...]
A new research centre receiving up to £50m over 14 years will develop brain stimulation devices to treat Parkinson’s, dementia, stroke and childhood epilepsy. The Medical Research Council Centre of Research Excellence (CoRE) in Restorative Neural Dynamics will explore how patterns of brain activity relate to behaviour and contribute to neurological disorders. Researchers aim to [...]
Weight loss injections may cut dementia and stroke risk in people with type 2 diabetes and obesity, according to new global research. People taking the drugs were also 30 per cent less likely to die during the follow-up period. Known as GLP agonist drugs, they help regulate blood sugar and appetite by slowing digestion, reducing [...]
A widely used cough medicine may help slow the progression of dementia in people with Parkinson’s disease, new research suggests. The 12-month clinical trial tested Ambroxol – a drug used for decades in Europe to treat respiratory conditions – for its potential to protect brain function in people with Parkinson’s disease dementia. The study included [...]
NR Times explores the latest research developments in the world of neuro rehabilitation. Four key pathways to Alzheimer’s disease mapped by researchers Four distinct pathways that lead to Alzheimer's disease have been identified by researchers, offering new insights into how the condition develops over time rather than from isolated risk factors. The pathways [...]
